Black Bird Biotech, Inc. filed its 10-K on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, Farmer, Fuqua & Huff, P.C. , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
04-16 | Black Bird Biotech, Inc. Appoints Nelson Grist as New CEO | CI |
04-16 | Black Bird Biotech, Inc. Appoints Nelson Grist as Its Future Member of Its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 298K | |
+42.38% | 6.26B | |
-15.86% | 4.49B | |
+6.36% | 3.29B | |
-11.28% | 3.12B | |
-3.23% | 2.5B | |
+45.24% | 1.94B | |
-7.89% | 1.68B | |
-0.98% | 1.63B | |
-11.32% | 1.56B |
- Stock Market
- Equities
- BBBT Stock
- News Black Bird Biotech, Inc.
- Black Bird Biotech, Inc. Auditor Raises 'Going Concern' Doubt